| Darrin Blane Letsinger, MD | |
|
1444 Peterman Dr, Alexandria, LA 71301-3432 | |
| (318) 442-5399 | |
| (318) 442-1586 |
| Full Name | Darrin Blane Letsinger |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 1444 Peterman Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083822886 | NPI | - | NPPES |
| 1164950 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 202017 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus St Frances Cabrini Hospital | Alexandria, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-louisiana Anesthesia Consultants, Apmc | 3971408733 | 53 |
News Archive
Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy.
Patients with prediabetes who also have obstructive sleep apnea may improve their resting heart rate, an important measure of cardiovascular health, by using continuous positive airway pressure to treat their OSA, according to a randomized, controlled trial presented at the ATS 2018 International Conference.
Coronaviruses irradiated with simulated sunlight used to infect cells showed reduced infectivity and reduced viral replication compared to viruses that were not irradiated.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
› Verified 3 days ago
| Entity Name | Mid-louisiana Anesthesia Consultants, Apmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205888914 PECOS PAC ID: 3971408733 Enrollment ID: O20031204000583 |
News Archive
Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy.
Patients with prediabetes who also have obstructive sleep apnea may improve their resting heart rate, an important measure of cardiovascular health, by using continuous positive airway pressure to treat their OSA, according to a randomized, controlled trial presented at the ATS 2018 International Conference.
Coronaviruses irradiated with simulated sunlight used to infect cells showed reduced infectivity and reduced viral replication compared to viruses that were not irradiated.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darrin Blane Letsinger, MD Po Box 5887, Alexandria, LA 71307-5887 Ph: (318) 442-5399 | Darrin Blane Letsinger, MD 1444 Peterman Dr, Alexandria, LA 71301-3432 Ph: (318) 442-5399 |
News Archive
Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy.
Patients with prediabetes who also have obstructive sleep apnea may improve their resting heart rate, an important measure of cardiovascular health, by using continuous positive airway pressure to treat their OSA, according to a randomized, controlled trial presented at the ATS 2018 International Conference.
Coronaviruses irradiated with simulated sunlight used to infect cells showed reduced infectivity and reduced viral replication compared to viruses that were not irradiated.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
› Verified 3 days ago
Paul Albares, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 318-442-5399 | |
Christine Elizabeth Taylor, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 651 N Bolton Ave, Alexandria, LA 71301 Phone: 318-443-3511 Fax: 318-757-9668 | |
Leo E Futrell Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 651 N Bolton Ave, Alexandria, LA 71301 Phone: 318-443-3511 | |
Taten Peterman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 | |
Mr. Francis X Robichaux, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 | |
William M Ellis Iii, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 318-473-3000 |